|
- Low-Dose Aspirin Is Safe and Effective for Prevention of Venous . . .
Recent evidence demonstrates that aspirin (ASA) may be safe and effective for VTE prevention in these patients The purpose of this study was to determine the safety and efficacy of low-dose ASA (81 mg) compared to non-ASA agents after arthroplasty for femoral neck fracture
- Aspirin for Venous Thromboembolism Prophylaxis in Hip Fracture, Total . . .
Aspirin is widely prescribed for venous thromboembolism prophylaxis in major orthopedic surgery We review the epidemiology of hip fracture, total knee arthroplasty, and total hip arthroplasty, and describe aspirin's mechanisms of action, efficacy, and safety
- A Systematic Review on the Use of Aspirin in the Prevention of Deep . . .
Emerging clinical evidence suggests that aspirin could be just as effective as anticoagulants with a lower cost The aim of this study was to provide an update based on literature of the past 3 years for the use of aspirin as thromboprophylaxis after knee and hip arthroplasty
- Is aspirin enough for venous thromboembolism prophylaxis?
O’Hara and colleagues therefore devised a scenario-based survey of US orthopedic and trauma providers regarding their adoption of ASA for venous thromboembolism (VTE) prophylaxis among inpatient and outpatient populations 2 With 287 respondents, the authors found that ASA was prescribed in only 13% of inpatients
- Aspirin for the extended prevention of venous thromboembolism . . . - Nature
Low-dose aspirin (100 mg) did not significantly reduce the incidence of VTE, DVT, or PE Aspirin increased the risks of overall and major bleeding but did not elevate blood transfusion
- Quick summary of antiplatelet agents for vascular surgeons: (1) give . . .
Quick summary of antiplatelet agents for vascular surgeons: (1) give aspirin or clopidogrel for symptomatic patients with lower extremity arterial disease and carotid stenosis and after arterial surgery and (2) give both after endovascular interventions
- Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a . . .
Findings from recent trials and meta-analyses suggest that aspirin may be an effective thromboprophylaxis alternative to low-molecular-weight heparin in patients who have undergone total joint
- Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee . . .
Anticoagulants for preventing VTE include simple oral agents (aspirin), injectable agents (low-molecular-weight heparin [LMWH]), and newer oral agents (dabigatran etexilate and rivaroxaban)
|
|
|